Abstract: The method for making a marine antifouling coating comprising a hydrophobic polymeric material formed by reacting a mixture comprising at least one ethylene propylene diene terpolymer (EPDM). The terpolymer component can comprises from 4 weight percent to 50 weight percent of random covalently linked monomers of ethylene and propylene and 0.25 weight percent to 15 weight percent of the polymer component is a non-conjugated diene, a first co-agent of polybutadiene, a second co-agent of an acrylate or methacrylate in a solvent with at least one peroxide.

Abstract: A marine antifouling coating comprising a hydrophobic polymeric material formed by reacting a mixture comprising at least one ethylene propylene diene terpolymer, wherein the terpolymer component comprises from 4 weight percent to 50 weight percent of random covalently linked monomers of ethylene and propylene and 0.25 weight percent to 15 weight percent of the polymer component is a non-conjugated diene, a first co-agent of polybutadiene, a second co-agent of an acrylate or methacrylate in a solvent with at least one peroxide. The marine antifouling coating is used for application to a surface of a marine vessel.

Abstract: A high solids cross-linked ethylene propylene diene terpolymer latex consisting of 15 weight percent to 88 weight percent ethylene propylene diene terpolymer with a molecular weight from 1300000 Mw to 5000 Mw, 10 weight percent to 70 weight percent of a water, 1 weight percent to 15 weight percent of a surfactant, and 0.3 weight percent to 1.76 weight percent of a curative.

Abstract: Latex blend formulations that include a high solids cross-linked ethylene propylene diene terpolymer latex with acrylics, polyurethane, epoxy, or alkyd resin usable as a waterproofing material for roofs or usable in paints and adhesives.

Abstract: A solvent free method for making an ethylene propylene diene terpolymer latex by blending water with 1 weight percent to 50 weight percent surfactant; blending solvent free ethylene propylene diene terpolymer with the water and surfactant at a low pressure to form a terpolymer mixture; high shear mixing the terpolymer mixture at 0.5 atm to 1.5 atm for 5 minutes to 24 hours at a temperature from 20 degrees Celsius to 100 degrees Celsius to form a solvent free ethylene propylene diene terpolymer latex formation, wherein the solvent free ethylene propylene diene terpolymer latex formation has a viscosity from 1 centipoise to 2000 centipoise; a density from 0.8 to 1.1; and a shelf life of from 7 days to 365 days without separating or stratifying.

Abstract: A durable ambient light curable waterproof liquid rubber coating with volatile organic compound (VOC) content of less than 450 grams per liter made from ethylene propylene diene terpolymer (EPDM) in a solvent, a photoinitiator, an additive, pigments, and fillers, and a co-agent and a method for making the formulation, wherein the formulation is devoid of thermally activated accelerators.

Abstract: Latex blend formulations that include a high solids cross-linked ethylene propylene diene terpolymer latex with acrylics, polyurethane, epoxy, or alkyd resin usable as a waterproofing material for roofs or usable in paints and adhesives.

Abstract: A durable ambient light curable waterproof liquid rubber coating with volatile organic compound (VOC) content of less than 450 grams per liter made from ethylene propylene diene terpolymer (EPDM) in a solvent, a photoinitiator, an additive, pigments, and fillers, and a co-agent and a method for making the formulation, wherein the formulation is devoid of thermally activated accelerators.

Abstract: A low pressure, low volatile, low energy method to make an ethylene, propylene diene terpolymer latex usable in paints, adhesives, and as a coating.

Abstract: A durable ambient light curable waterproof liquid rubber coating with volatile organic compound (VOC) content of less than 450 grams per liter made from ethylene propylene diene terpolymer (EPDM) in a solvent, a photoinitiator, an additive, pigments, and fillers, and a co-agent and a method for making the formulation, wherein the formulation is devoid of thermally activated accelerators.

Abstract: A durable ambient light curable waterproof liquid rubber coating with volatile organic compound (VOC) content of less than 450 grams per liter made from ethylene propylene diene terpolymer (EPDM) in a solvent, a photoinitiator, an additive, pigments, and fillers, and a co-agent and a method for making the formulation, wherein the formulation is devoid of thermally activated accelerators.

Abstract: Receiving results of detecting whether each service node in a service node pool is faulty transmitted by service request nodes; and determining fault indication states of a service node itself and other service nodes according to the results of detecting; or expanding an echo request message which carries a result of detecting, by a service request node itself, whether each service node in a service node pool is faulty during a previous period of a current period; and transmitting the echo request message to each service node at the beginning of the current period to enable each service node to determine fault indication states of a service node itself and other service nodes according to the result of detecting. According to the foregoing solutions of the present invention, reliability of service node fault detection is improved.

Abstract: The present invention discloses a method of producing polypeptides, including insulinotropic GLP-1 (7-36) polypeptide and/or GLP-1 analogs, by ligating genes in a tandem way. Also disclosed are the recombinant polypeptides produced by such a method. Using the method of this invention, 1 to 32 copies of GLP-1 (7-36) and/or GLP-1 analog genes may be expressed in tandem and the desired polypeptide can be obtained after cleavage of a fusion protein and further processes of separation and purification thus making possible the production of recombinant polypeptides, including recombinant GLP-1 (7-36) and/or GLP-1 analogs on a large scale, at a significantly reduced production cost.

Abstract: The present invention is directed to the development of novel exendin-4 derivatives exhibiting advantageous glucose-regulatory properties, and to methods of producing these derivatives, including recombinant methods in which these derivatives are produced by cleavage of a fusion protein containing multiple copies of the exendin-4 derivative peptide. The methods of the present invention can be used to simplify the process of producing the disclosed exendin-4 derivatives, thereby lowering the cost of their production.

Abstract: The present invention provides a Magainin derivative peptide and method of production thereof. Also provided is a pharmaceutically composition comprising said Magainin derivative peptide and pharmaceutically acceptable carrier and/or pharmaceutically compatible binding agents. The Magainin derivative peptide of the present invention having amino acid sequence of the general formula shown as below: Gly-Ile-Gly-Lys-Phe-Leu-His-Ser-Ala-Lys-Lys-Phe-Gly-Lys-Ala-Phe-Val-Gly-Glu-Ile-X-Asn-Y-Z-OH in which: X is an amino acid residue selected from the group consisting of Met, Ile and Leu; Y is an amino acid residue selected from the group consisting of Ser, Lys, Ile, Arg and Leu; and Z is Arg.

Abstract: The present invention provides a Magainin derivative peptide and method of production thereof. Also provided is a pharmaceutically composition comprising said Magainin derivative peptide and pharmaceutically acceptable carrier and/or pharmaceutically compatible binding agents. The Magainin derivative peptide of the present invention having amino acid sequence of the general formula shown as below: ?????Gly-Ile-Gly-Lys-Phe-Leu-His-Ser-Ala-Lys-Lys- Phe-Gly-Lys-Ala-Phe-Val-Gly-Glu-Ile-X-Asn-Y-Z-OH in which: X is an amino acid residue selected from the group consisting of Met, Ile and Leu; Y is an amino acid residue selected from the group consisting of Ser, Lys, Ile, Arg and Leu; and Z is Arg.

Abstract: The present invention provides a Magainin derivative peptide and method of production thereof. Also provided is a pharmaceutically composition comprising said Magainin derivative peptide and pharmaceutically acceptable carrier and/or pharmaceutically compatible binding agents.

Abstract: The present invention discloses a method of producing polypeptides, including insulinotropic GLP-1 (7-36) polypeptide and/or GLP-1 analogs, by ligating genes in a tandem way. Also disclosed are the recombinant polypeptides produced by such a method. Using the method of this invention, 1 to 32 copies of GLP-1(7-36) and/or GLP-1 analog genes may be expressed in tandem and the desired polypeptide can be obtained after cleavage of a fusion protein and further processes of separation and purification thus making possible the production of recombinant polypeptides, including recombinant GLP-1(7-36) and/or GLP-1 analogs on a large scale, at a significantly reduced production cost.

Abstract: The present invention is directed to the development of novel exendin-4 derivatives exhibiting advantageous glucose-regulatory properties, and to methods of producing these derivatives, including recombinant methods in which these derivatives are produced by cleavage of a fusion protein containing multiple copies of the exendin-4 derivative peptide. The methods of the present invention can be used to simplify the process of producing the disclosed exendin-4 derivatives, thereby lowering the cost of their production.